WHO panel OKs emergency use of China’s Sinopharm vaccine
Pfizer to seek approval in fall for COVID-19 vaccine use in children aged 2 to 11
7 May 2021Why is COVID-19 so hard to treat? Growing evidence points to unique infectious profile
7 May 2021WHO panel OKs emergency use of China’s Sinopharm vaccine
The World Health Organization gave emergency use authorization Friday to a COVID-19 vaccine manufactured by China’s Sinopharm, potentially paving the way for millions of the doses to reach needy countries through a U.N.-backed program rolling out coronavirus vaccines.
